Obesity and adiponectin after kidney transplantation

Acta Physiologica Hungarica

Volumn 94, Issue 1-2, 2007, Pages 149-157

  Teplan, Vladimir ^a,b   Schuck O ^a,b   Stollova, M ^a,b   Vitko, S ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b IPVZ   (Czech Republic)

Author keywords

Adiponectin; Atherosclerosis; Hyperlipidaemia; Kidney transplantation; Leptin; Obesity

Indexed keywords

ADIPONECTIN; LEPTIN;

ARTICLE; ATHEROSCLEROSIS; BLOOD; BODY MASS; EVALUATION; HYPERLIPIDEMIA; KIDNEY TRANSPLANTATION; LOW CALORY DIET; OBESITY; PROSPECTIVE STUDY;

ADIPONECTIN; ATHEROSCLEROSIS; BODY MASS INDEX; DIET, REDUCING; HYPERLIPIDEMIAS; KIDNEY TRANSPLANTATION; LEPTIN; OBESITY; PROSPECTIVE STUDIES;

EID: 34248199300     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.94.2007.1-2.14     Document Type: Article

References (31)

1. Gore JL, Pham PT, Danovitch M et al.: Obesity and outcome following renal transplantation. Am. J. Transplant. 6, 357-363 (2006)
2. Cofán F, Vela E, Cléries M et al.: Obesity in renal transplantation: Analysis of 2694 patients. Transpl. Proc. 37, 3695-3697 (2005)
3. Jindal RM, Zawada ET Jr: Obesity and kidney transplantation. Am. J. Kidney Dis. 43(6), 943-952 (2004)
4. Zoccali C, Mallamaci F, Tripepi G et al.: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end stage renal disease. J. Am. Soc. Nephrol. 13, 134-141 (2002)
5. Chudek J, Adamczak M, Karkoszka H et al.: Plasma adiponectin concentration before and after successful kidney transplantation. Transplant. Proc. 35(6), 2186-2189 (2003)
6. Szolkiewicz M, Sucajtys E, Wolyniec W et al.: Mechanisms of enhanced carbohydrate and lipid metabolism on adipose tissue in uraemia. J. Ren. Nutrition 15(1), 166-172 (2005)
7. Sharma AM, Chettey VT: Obesity, hypertension and insulin resistance. Acta Diabetol. 42, Suppl 1, S3-8 (2005)
8. de Mattos AM, Prather J, Olyaei AJ et al.: Cardiovascular events following renal transplantation: Role of traditional and transplant-specific risk factors. Kidney Int. 70, 757-764 (2006)
9. Fazalzadeh A, Mehdiazadeh A, Ostoran MA, Raiss-Jalalli GA: Incidence of cardiovascular risk factors and complications before and after kidney transplantation. Transplant. Proc. 38, 506-508 (2006)
10. Teplan V, Poledne R, Schück O, Ritz E, Vitko S: Hyperlipidaemia and obesity after renal transplantation. Ann. Transplant. 6, 21-23 (2001)
11. Teplan V, Schück O, Štollová M, Vítko Š: Obesity and hyperhomocysteinaemia after kidney transplantation. Nephrol. Dial. Transpl. 18[Suppl 5], 71-73 (2003)
12. Meier-Kriesche HV, Arndorfer JA, Kaplan B: The impact of body risk factor for graft failure and patient death. Transplantation 73, 70-74 (2002)
13. Armstrong KA, Campbell SB, Hawley CH et al.: Impact of obesity on renal transplant outcomes. Nephrology 10, 405-413 (2005)
14. Wiecek A, Kokot F, Chudek J et al.: The adipose tissue a novel endocrine organ of interest to the nephrologist. Nephrol. Dial. Transplant. 17, 191-197 (2002)
15. Wellen KE, Hotamisligil GS: Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112, 1785-1788 (2003)
16. Boots JM, Christiaens MH, van Hoof JP: Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk. Drugs 64(18), 2047-2073 (2004)
17. Kasap B, Soylu A, Türkmen M, Karakcu S, Bora S, Gülay H: Effect of obesity and overweight on cyclosporine blood levels and renal functions in renal adolescent recipients. Transplant. Proc. 38, 463-465 (2006)
18. Praga M: Obesity - a neglected culprit in renal disease. Nephrol. Dial. Transplant. 17, 1157-1158 (2002)
19. Axelsson J, Heimbürger O, Lindholm B, Steinvinkel P: Adipose tissue and its relation to inflammation: the role of adipokines. J. Ren. Nutrition 15(1), 131-136 (2005)
20. Zoccali C, Mallamaci F, Tripepi G: Adipose tissue as a source of inflammatory cytokines in health and disease: Focus to end-stage renal disease. Kidney Int. 63(Suppl 84), S65-S68 (2003)
21. Haluzik M, Parizkova J, Haluzik MM: Adiponectin and its role in the obesity-indued insulin resistance and related complications. Physiol. Res. 53, 123-129 (2004)
22. Zoccali C, Mallamaci F, Tripepi G et al.: Adiponectin, metabolic risk factors, and cardiovascular events among patients with and stage renal disease. J. Am. Soc. Nephrol. 13, 134-141 (2002)
23. Krzyzanowska K, Mittermayer F, Kopp H-P, Wolzt M, Schernthaner G: Weight loss reduces circulating asymmetrical dimethylarginine concentration in morbidity obese women. J. Clin. Endocrinol. Metab. 89(12), 6277-6281 (2004)
24. Havel PJ: Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein and adiponectin. Curr. Opin. Lipidol. 13, 51-59 (2002)
25. Stenvienkel P, Marchlewska A, Pecoits-Filho R et al.: Adiponectin in renal disease: relationship to phenotype and genetic variation of the gene encoding adiponectin. Kidney Int. 65, 274-281 (2003)
26. Shemin D, Bostom AG, Selhub J: Treatment of hyperhomocysteinaemia in end-stage renal disease. Am. J. Kidney Dis. 38(Suppl 1), 91-94 (2001)
27. Considine RV, Sinha MK, Heiman ML et al.: Serum immunoreactive leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292-295 (1996)
28. Perna AF, Ingrasso D, De Santo NG: Metabolic consequences of folate induced reduction of hyperhomocysteinemia in uremia. J. Am. Soc. Nephrol. 8, 1899-1905 (1997)
29. Wallace AM, McMahon AD, Packard CJ et al.: Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104, 3052-3056 (2001)
30. Pecoits-Filho R, Nordfors L, Heimbürge O et al.: Soluble leptin receptors and serum leptin in end-stage renal disease: Relationship with inflammation and body composition. Eur. J. Clin. Invest. 11, 17 (2002)
31. Kokot F, Adamczak M, Wiecek A: Plasma leptin concentration in kidney transplant patients during the early post-transplant period. Nephrol. Dial. Transplant. 13, 2276-2280 (1998)